TP63 and head and neck squamous cell carcinoma: An alteration of the expression of a amino-shorter isoform of p63 (ΔΝp63), codified by the second promoter, seems to play a pivotal role in HNSCC; indeed, recent studies indicate its involvement in aberrated cell survival, renewal, and senescence suppression [43–45].